{
    "2021-12-09": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Beovu",
                        "Trial",
                        "Diabetic Macular Edema",
                        "Results"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "Vasant Narasimhan",
                        "Consistent Growth",
                        "Cash"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}